SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 189.96-0.1%12:44 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (29287)9/19/1999 9:47:00 AM
From: Arthur Radley  Read Replies (1) of 32384
 
Happened to find my annual report last night and was reviewing the projections for 1999. As for NDA's planned, I see the following:
1) Targretin capsules
2) Targretin gel
3) Panretin capsules
4) Elan filing for Morphelan

Report also indicates that Cytel would report on Cylexin that is in Phase III testing. Did I miss an update on this drug or has anything happened to move this drug forward in the process of filing an NDA?

Considering we only have on 3 1/2 months to go in 1999, if they meet the projections with these 4 drugs....the next few weeks should be very interesting.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext